Ping-chen Hou
138 Sheng Li Road
Tainan, TNQ, Taiwan
Tainan, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Epidermolysis bullosa pruriginosa: A retrospective cohort study highlighting secondary cutaneous amyloidosis and response to Janus kinase inhibition.
Journal: JAAD international
Published: August 23, 2026
Genotype-Phenotype Correlations in Recessive Dystrophic Epidermolysis Bullosa: A Systematic Review.
Journal: JAMA dermatology
Published: February 04, 2026
Large cellulitis-like erythematous plaques with overlying nodules on bilateral shins.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: September 06, 2025
Synergistic enhancement of PD-L1 expression from DNA repair dysfunction and UV exposure in xeroderma pigmentosum: Potential therapeutic role of PD-L1 inhibitors.
Journal: Journal of dermatological science
Published: May 08, 2025
Missense and Inframe Pathogenic Variants in PLEC Lead to Minimal or Delayed-Onset Muscular Dystrophy in Autosomal Recessive Epidermolysis Bullosa Simplex: A Genotype-Phenotype Correlation in Nine Cases.
Journal: The Journal of dermatology
Published: April 25, 2025
Revisiting the Pathology of Bullous Pemphigoid: Basal Cell Necrosis as a Diagnostic Clue and Its Pathogenic Role.
Journal: The Journal of dermatology
Published: March 13, 2025
Real-world experience of using dupilumab and JAK inhibitors to manage pruritus in epidermolysis bullosa pruriginosa.
Journal: Skin health and disease
Published: October 02, 2024
Transcriptomic response of peripheral blood mononuclear cells to secukinumab in epidermolytic ichthyosis.
Journal: Clinical and experimental dermatology
Published: December 17, 2023
Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ T helper 2 cells which may contribute to pruritus in lesional skin.
Journal: The British journal of dermatology
Published: September 02, 2023
Th2 response drives itch in dystrophic epidermolysis bullosa pruriginosa: A case-control study.
Journal: Journal of the American Academy of Dermatology
Published: August 10, 2023
Innovations in the Treatment of Dystrophic Epidermolysis Bullosa (DEB): Current Landscape and Prospects.
Journal: Therapeutics and clinical risk management
Published: April 26, 2023
Mutational analysis of epidermolysis bullosa in Taiwan by whole-exome sequencing complemented by RNA sequencing: a series of 77 patients.
Journal: Orphanet journal of rare diseases
Published: August 28, 2022
Last Updated: 09/26/2026